Literature DB >> 2439653

Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin.

G Gerna, M G Revello, M Dovis, E Petruzzelli, G Achilli, E Percivalle, M Torsellini.   

Abstract

Using murine monoclonal antibodies (MAbs) to rubella virus haemagglutinin, five epitopes were identified in competitive ELISA binding assays: A, B, D and E by haemagglutination-inhibiting (HI) MAbs with no neutralizing (Nt) activity, and C by a MAb with neither activity. However, when HI and Nt activities were determined in the presence of anti-mouse immunoglobulins, epitopes A, B and D were defined by both HI and Nt MAbs, whereas epitopes C and E were identified by HI MAbs without Nt activity. A synergistic Nt activity, in the absence of anti-mouse immunoglobulins, was displayed by mixtures of antibodies of different epitope groups. Analysis of mixtures of MAb pairs each belonging to a different epitope class, showed that synergistic Nt activity was elicited primarily by the group A epitope, secondarily by groups B and D and only minimally by groups C and E.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439653     DOI: 10.1099/0022-1317-68-7-2007

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR.

Authors:  M G Revello; F Baldanti; A Sarasini; M Zavattoni; M Torsellini; G Gerna
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.

Authors:  P Cordoba; S L Grutadauria; C Cuffini; M T Zapata
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.

Authors:  J S Wolinsky; M McCarthy; O Allen-Cannady; W T Moore; R Jin; S N Cao; A Lovett; D Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.

Authors:  F Verrier; A Nádas; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.

Authors:  S Laal; S Burda; M K Gorny; S Karwowska; A Buchbinder; S Zolla-Pazner
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 7.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.